Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2025-12-25 @ 12:43 AM
NCT ID:
NCT02680067
Eligibility Criteria:
Inclusion Criteria:
* Ability to provide written informed consent
* Subjects can be either gender but must be at least 18 years old.
* Rheumatoid arthritis subjects may fulfill 2010 American College of Rheumatology criteria.
* Active rheumatoid arthritis subjects, with at least 2 tender or swollen joints.
* Subjects participating in the clearance arm of the study must not have ICG injections for at least 10 weeks.
Exclusion Criteria:
* Individuals with active systemic disorders or inflammatory conditions other than rheumatoid arthritis, (such as chronic infections with hepatitis B, hepatitis C or HIV) that would confound the study results.
* Known sensitivity to iodine because of residual iodide in Indocyanine Green
* Pregnant women should not participate.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
89 Years
Study:
NCT02680067
Study Brief:
Protocol Section:
NCT02680067